In this study, a fibronectin inhibitor, the peptide arginine-glycine-aspartic acid-serine (Arg-Gly-Asp-Ser; RGDS), was used to functionalize HMW-HA and produce a matrix that promotes GBM cell attachment while inhibiting pro-tumorigenic signals. Here, FN1 is linked to glioblastoma.